Patched 1-interacting Peptide Represses Fibrosis in Pancreatic Cancer to Augment the Effectiveness of Immunotherapy
Yasuhiro Oyama, Masafumi Nakamura(Shizuoka Cancer Center), Kenoki Ohuchida(Kyushu University), Shu Ichimiya(Kyushu University), Makoto Kawamoto(Kyushu University), Hideya Onishi(Pancreas Centre (Canada)), Masayo Umebayashi(Saiseikai Fukuoka General Hospital), Akiko Fujimura(The University of Tokyo), Takashi Morisaki(Saiseikai Fukuoka General Hospital), Satoko Koga, Mutsunori Murahashi(Jikei University School of Medicine), Kazunori Nakayama(Kyushu University), Akira Imaizumi(Ajinomoto (Japan))
Cited by 17
Related Papers
Phase I clinical trial of a five-peptide cancer vaccine combined with cyclophosphamide in advanced solid tumors
|Clinical Immunology|2016|62
Identification of Tumoricidal TCRs from Tumor-Infiltrating Lymphocytes by Single-Cell Analysis
|Cancer Immunology Research|2018|36
Propensity score-matched analysis of internal stent vs external stent for pancreatojejunostomy during pancreaticoduodenectomy: Japanese-Korean cooperative project
|Pancreatology|2020|34
RBPJ and MAML3: Potential Therapeutic Targets for Small Cell Lung Cancer
|Anticancer Research|2018|20